Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 552001 - 552020 out of 553606 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FF10) retifanlimab | ZYNYZ 25MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Merkel Cell | IncyteCorporation |
| USA | (L01FG01) bevacizumab | ALYMSYS 100MG | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | AmnealPharmaceuticalsofNewYork,LLC |
| USA | (L01FG01) bevacizumab | ALYMSYS 100MG | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | AmnealPharmaceuticalsofNewYork,LLC |
| USA | (L01FG01) bevacizumab | ALYMSYS 400MG | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | AmnealPharmaceuticalsofNewYork,LLC |
| USA | (L01FG01) bevacizumab | ALYMSYS 400MG | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | AmnealPharmaceuticalsofNewYork,LLC |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteCorporation |
| USA | (L01FX12) tafasitamab | MONJUVI 200MG INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteCorporation |
| USA | (L01FX15) belantamab mafodotin | BLENREP 70MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | GlaxoSmithKline |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN 5MG/ML (PF) INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BaxterHealthcareCorporation |
| USA | (L01XA03) oxaliplatin | OXALIPLATIN 5MG/ML (PF) INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BaxterHealthcareCorporation |
| USA | (L01XG01) bortezomib | BORTEZOMIB (EQV-VELCADE) 3.5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FreseniusKabi,LLC |
| USA | (L01XG02) carfilzomib | KYPROLIS 10MG VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenUSA,Inc. |
| USA | (L01XG02) carfilzomib | KYPROLIS 10MG VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenUSA,Inc. |
| USA | (L01XM02) ivosidenib | TIBSOVO 250MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Cholangiocarcinoma | ServierPharmaceuticalsLLC |
| USA | (L01XM02) ivosidenib | TIBSOVO 250MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Cholangiocarcinoma | ServierPharmaceuticalsLLC |
| USA | (L01XM04) vorasidenib | VORANIGO 10MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Oligodendroglioma;Astrocytoma | ServierPharmaceuticalsLLC |
| USA | (L01XM04) vorasidenib | VORANIGO 10MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Oligodendroglioma;Astrocytoma | ServierPharmaceuticalsLLC |
| USA | (L01XM04) vorasidenib | VORANIGO 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Oligodendroglioma;Astrocytoma | ServierPharmaceuticalsLLC |
Pages
